Elekta AB (publ)
STO:EKTA B

Watchlist Manager
Elekta AB (publ) Logo
Elekta AB (publ)
STO:EKTA B
Watchlist
Price: 63.1 SEK 2.1% Market Closed
Market Cap: 24.1B SEK
Have any thoughts about
Elekta AB (publ)?
Write Note

Elekta AB (publ)
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Elekta AB (publ)
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Elekta AB (publ)
STO:EKTA B
Research & Development
-kr830m
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Research & Development
-kr185.7m
CAGR 3-Years
-78%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Research & Development
-kr86.3m
CAGR 3-Years
-39%
CAGR 5-Years
-10%
CAGR 10-Years
-16%
Getinge AB
STO:GETI B
Research & Development
-kr1.1B
CAGR 3-Years
-14%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Research & Development
-kr149m
CAGR 3-Years
-9%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Elekta AB (publ)
Glance View

Market Cap
24.1B SEK
Industry
Health Care

Elekta AB operates as a medical technology company. The company is headquartered in Stockholm, Stockholm and currently employs 4,591 full-time employees. The firm offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The firm has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The firm owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).

EKTA B Intrinsic Value
96.33 SEK
Undervaluation 34%
Intrinsic Value
Price

See Also

What is Elekta AB (publ)'s Research & Development?
Research & Development
-830m SEK

Based on the financial report for Apr 30, 2024, Elekta AB (publ)'s Research & Development amounts to -830m SEK.

What is Elekta AB (publ)'s Research & Development growth rate?
Research & Development CAGR 5Y
1%

Over the last year, the Research & Development growth was 1%. The average annual Research & Development growth rates for Elekta AB (publ) have been -3% over the past three years , 1% over the past five years .

Back to Top